SCHEMBL4353306

SCHEMBL4353306

Nc1ncnc2[nH]cc(-c3cccc(F)c3)c12

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 10/20 0.62
STK4 Q13043 4/20 0.62
STK3 Q13188 4/20 0.62
MAP4K4 O95819 4/20 0.55
CDK2 P24941 2/20 0.55
CDC7 O00311 1/20 0.55
ROCK2 O75116 1/20 0.55
PIM1 P11309 1/20 0.55
PRKACA P17612 1/20 0.55
GSK3B P49841 1/20 0.55
HIPK2 Q9H2X6 1/20 0.55
CLK4 Q9HAZ1 1/20 0.55
IRAK4 Q9NWZ3 1/20 0.55
JAK3 P52333 3/20 0.53
RIPK2 O43353 1/20 0.47
JAK2 O60674 2/20 0.46
CCNT1 O60563 1/20 0.46
CCNA2 P20248 1/20 0.46
CDK9 P50750 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350720 0.83 STK4 (0.68) LRRK2STK4STK3MAP4K4
SCHEMBL12438584 0.83 LRRK2 (0.55) LRRK2STK4STK3MAP4K4CDC7
SCHEMBL8107168 0.83 LRRK2 (0.62) LRRK2STK4STK3MAP4K4CDK2
SCHEMBL8114068 0.83 ADK (0.49) LRRK2STK4STK3
SCHEMBL8112985 0.82 CCNT1 (0.48) LRRK2STK4STK3MAP4K4CDK2
SCHEMBL4352960 0.82 LRRK2 (0.58) LRRK2STK4STK3MAP4K4CDC7
SCHEMBL7021288 0.82 LRRK2 (0.63) LRRK2STK4STK3MAP4K4CDK2
SCHEMBL31531349 0.80 FLT3 (0.51) LRRK2STK4STK3MAP4K4RIPK2
SCHEMBL7013879 0.80 LRRK2 (0.65) LRRK2STK4STK3MAP4K4
SCHEMBL15401813 0.79 LRRK2 (0.83) LRRK2STK4STK3CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009070328-A1 MODULATORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY FOR USE IN THE TREATMENT OR PREVENTION OF SUBSTANCE ABUSE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-06-04 WO disclosed
EP-0888353-B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2003-07-09 EP disclosed
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed